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ABSTRACT 
Nano discs recently evolved as a novel tool for studying the membrane associated proteins and serve as an effective drug delivery system. Nano 
discs constitute disc shaped nano particles and can be defined as a membrane system which is synthetic in nature and aids in the study of 
membrane proteins. It is mainly made of phospholipid bilayer and the water repelling edge is isolated by amphipathic proteins called Membrane 
Scaffolding Proteins [MSP]. Micelles present in the nano disc mimics the property of the biological membrane proteins. It is a powerful technology 
that competently delivers the drug components in to the right cells in the right tissues. Membrane scaffold proteins are primarily expressed, 
purified and characterized and self-assembled to form Nano discs by the process of dialysis using biobeads. Nano discs are proven to be effective in 
the study of membrane proteins because they can fluidize and counterbalance and also help in reclusion, refinement, biophysical and biochemical 
studies of them. It also presents a more genuine environment than liposomes, bicelles, amphipols and detergent micelles. Major technological 
advantages of nano discs include the higher stability and carrier capacity and also the increased feasibility of incorporating both hydrophilic and 
hydrophobic substances of drug carrier. Thus nano discs serves as an excellent system in its ability to precisely control its composition and provide 
a nano scale membrane surface for investigating molecular recognition events. This article reviews the emphasis of nanodiscs in studying 
membrane proteins as well as its effectivity in transforming into a major drug delivery system. An overview of published literatures between 1996 
and 2017 was conducted to write the review. 
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What is nano drug delivery? 
The technique by which drug delivery is achieved has a vital role in 
its performance. `Nanoparticles are solid colloidal dispersions 
having their size in nanometer range [10-1000 nm] [1]. They have 
the capacity to transform poorly soluble, poorly absorbable, liable 
biologically active substances into promising deliverable drugs. 
Nanoparticles have tremendous potential in effective drug delivery. 
The drug to be delivered is dissolved, encapsulated, entrapped or 
incorporated into a nanoparticle matrix system. The most common 
method is by loading the therapeutic agents within the nano 
particles [2]. Due to the very small size and miniscule diameter, it can 
easily penetrate the blood capillaries and reach the target site and 
effectively deliver the drug in the required therapeutic concentrations 
[3]. Thus by doing in this way, it reduces drug toxicity as well as side 
effects and enhances drugefficacy. Nanotechnology has gained 
publicity these days to overcome the problems of gene and drug 
delivery [4]. The widespread improvements in technological 
innovations have begun to change the fundamentals of diagnosis, 
treatment and prevention of diseases. Such technological innovations 
are referred to as nano medicines [5] and they have the potential to 
convert upcoming molecular discoveries from proteomics and 
genomics into huge beneficiary aspects for the patient [6].  
Why nano drug delivery? 
The rapid enhancement and progress in nanotechnology during the 
last years has found out that drug delivery methodologies involving 
nanoparticles will serve effectively as well as efficiently [7] Even, 
nano gold particles has found its application in the field of bio 
pharmaceutics [8]. Nanoparticles have the potential to deliver the 
therapeutic agents accurately as well as carefully into the target site, 
whether it is an organ, tissue or even a specific cell and also result in 
the precise release of the drug at the target site. Because of the 
colloidal nature and a very small diameter(less than 1000 nm), they 
can penetrate through the capillaries into the internal apparatus of 
even a single cell. The traditional drug delivery methods such as oral 
route and injection etc. may also find less applicable due to the 
following reasons, the most common one being the destruction of 
the drugs at common doses by the stomach as well as the intestinal 
juices. Thus it will result in poor or hampered absorption of the 
drugs into the body and will be non-productive or useless. The new 
evolution of nano drug delivery can compensate this in a promising 
way [9]. Nanoparticles are proven to have some additional 
advantages when compared with micro particles due to increased 
range of intracellular uptake, relative mobility and availability to 
large areas of biological targets. The small size, increased rate of 
solubility customised surface and multi functionality of 
nanoparticles will open a wider access to create newer applications 
of biomedicine. Thus the therapeutic as well as pharmacological 
actions of the drug being administered are enhanced. Moreover the 
novel properties of nanoparticles provide the possibility to interact 
with complex cellular functions [10]. Nanoparticles have the ability 
to mimic biological properties [e. g.: tissue engineering, infection] 
[11]. The development of huge nano scale interventions will change 
the scientific landscape in terms of diagnosis, prevention and 
treatment of illness. Interactions of nano particles with biological 
environment, therapeutic agent stability, cell signalling mechanisms, 
cell surface receptor targeting etc. are essential to attain effective 
drug delivery. Anticancer drugs like paclitaxel, dexamethasone and 
doxorubicin etc. have been formulated successfully using 
nanoparticles [12]. One of the most difficult malignancies to detect 
and treat is the brain cancer. The main problem residing with this is 
the difficulty in in getting imaging and the passing of therapeutic 
agents via the blood brain barrier and into the brain. Anticancer 
drugs like lopramide and doxorubicin bound to nano materials have 
proven to cross the blood brain barrier and released at therapeutic 
concentrations in the brain [13]. Nanoparticles used in drug delivery 
systems, for instance ophthalmic drug delivery are usually less than 
100 nano meter and is composed of biodegradable materials like 
lipids, natural or synthetic polymers etc [14]. Cells take up 
nanoparticles more effectively than micro molecules and serve as 
the effective transporter and delivery system. Also, nanoparticles 
being loaded with antiviral therapeutic agents against human 
immuno deficiency Virus are found as an emerging as well as 
promising drug delivery system in the treatment of acquired 
immuno deficiency syndrome (AIDS) [15]. The various nano 
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particles used in drug delivery include polymeric biodegradable 
nano particles, metallic nano particles, ceramic nano particles 
etc. The complete information regarding the nanoparticles used 
in drug delivery has been explained in Sandeep S et al. [16]. The 
experimentation in various micro as well as nano particles for 
efficient drug delivery has been checked from time immemorial, for 
instance magnetic microsphere experimentation for delivering drug 
into the colon region [17, 18]. Nanodiscs serve as an efficient 
membrane system involved in nano drug delivery. The use of 
nanodiscs in nano drug delivery is only an evolving or emerging 
system. Apart from the try-outs being conducted for effectively 
utilising nanodiscs in nano drug delivery, nanodiscs serve the 
prominent role in the study of membrane proteins [19]. 
Nanodiscs: the new revolution in membrane protein study 
Nanodiscs can be defined as disc shaped (discoidal) particles having 
a flattened or placoid bilayer composed of phospholipids and the 
bilayer is being enveloped by proteins (e. g.: apo lipoprotein A1)[20]. 
The bilayer is arranged in such a way that the hydrophobic end is 
directed inwards towards the opposite side of the film and the 
hydrophilic edge is directed outwards. Nanodiscs were first found 
out by Sligar and co-workers [21]. Nanodiscs constitute disc shaped 
nano particles and can also be defined as a membrane system which 
is synthetic in nature and aids in the study of membrane proteins 
[22]. It is mainly made of phospho lipid bilayer and the water 
repelling edge is isolated by amphipathic proteins called membrane 
scaffolding proteins [MSP]. They are cropped versions of 
apolipoprotein which cover around a strip of lipid bilayer and form a 
disc shaped particle or in other words nanodisc. They are arranged 
in a double belt model. In structure, they are identical to high density 
lipoproteins [23]. It is these membrane scaffolding proteins or in 
other words msps that determine the elongated structure of the 
nanodisc and it has also been found out that as temperature 
increases, the particle structure become more rounded or disc 
shaped [24]. MSPs are also involved in determining the thickness of 
the hydrophobic layer within the lipid bilayer. There is a chance of 
some disparity between the protein and phospholipid layer. This 
mismatch can also be challenged and overcome with the help of 
adjusting the scaffolding proteins. Nanodiscs are proven to be 
effective in the study of membrane proteins because they can 
fluidize and counterbalance and also help in reclusion, refinement, 
biophysical and biochemical studies of them. It also presents a more 
genuine environment than liposomes, bicelles, amphipols and 
detergent micelles [25]. The primary focus of nanodiscs lies in the 
study of membrane proteins and this can be achieved by dissolving 
them in solution. Peptide amphiphiles are primarily known to make 
nanodiscs. It is particularly composed of a peptide sequence, which is 
hydrophilic in nature and has a lipid chain attached to it (lipopeptide). 
However due to the relative unstability posed by these lipopeptides 
can be overcome by self-assembled amphiphilic peptides [26]. Major 
technological advantages of nanodiscs include the higher stability and 
carrier capacity and also the increased feasibility of incorporating both 
hydrophilic and hydrophobic substances of drug carrier [27]. A 
number of membrane proteins have been imbibed into nanodiscs. It 
include metabotropic glutamate receptor [28], parathyroid hormone 1 
receptor [29], bacterial chemoreceptors [30], cholera toxin [31] etc. 
Nanodiscs are found in nature as HDL [32]. These lipo protein particles 
flow through blood and act as a vehicle for carrying cholesterol to liver 
for downgrading. Primarily they are disc shaped in original form and 
on interpolation with cholestreryl esters in the phospholipid bilayer, 
they assume a sphere like form [33]. The size of a nanodisc is 
dependent on the length of modified apo A 1. Nanodiscs are even 
prepared from zebra fish apo A1 and are called as nanoscale 
apolipoprotein bound bilayers [22]. From human serum 
apolipoprotein has been directy derived and is used in the preparation 
of reoriented discs of lipids [34, 35]. 
The link from lipoproteins to nanodiscs and to membrane protein 
studies  
A lipoprotein can be defined as a biochemical assembly of lipids and 
proteins and aids in the transportation of cholesterol, fatty acids and 
lipids in the blood. The different types of lipoproteins include LDL, 
HDL, very low density lipoproteins (VLDL), chylomicron among 
these lipoproteins, the HDL is also known as good cholestrol because 
of its tremendous potential in transporting cholesterol from the 
walls of arteries to the liver where the cholesterol is being subjected 
to the process of degradation [36]. The reverse cholestrol transport 
pathway has something important to do with the HDL particles. The 
reverse cholesterol transport pathway involves many steps which 
ultimately results in the movement of cholesterol from the 
peripheral cells to the liver via the plasma compartment. Conversion 
of cholesterol from these peripheral sites to HDL can be done with 
the help of adenosine triphosphate binding casette Proteins [37]. 
The HDL is being composed of a protein part and phospholipid part. 
So, here the protein component of the HDL that is apolipoproteinA1 
act as an acceptor of the cholesterol particle while the phospholipid 
portion act as the sink. The enzyme lecithin acetyl transferase 
(LCAT) is involved in the conversion of cholesterol to cholesterol 
ester. In exchange for triglycerides, these cholestryl esters can be 
transferred to LDL, VLDL and other such lipoproteins. This step is 
being achieved with the help of a protein termed as cholesteryl ester 
transfer protein (CETP)[38)]. By the conversion of cholesterol into 
bile acids, these lipoproteins can be utilised. Another method for the 
take up of these lipoproteins is by secreting the non-esterified 
cholesterol into bile. So, the overall process of making, conversion 
and degradation of HDL particles is being up regulated by the 
reverse cholesterol transport pathway. The cholesterol moiety can 
then be converted to cholesteryl ester and then further to 
lipoproteins. Natural HDL is composed of diverse particles 
(heterogeneous in nature). This heterogeneity in particle nature will 
impede the physical as well as structural study of apolipoprotein A1 
[39]. Nanodiscs can be formulated by the reconstruction of these 
native HDL particles. This reconstitution process can be carried out 
with the help of purified Apo A1 and using different lipids having or 
even without having cholesterol. Thus the particles turned out to a 
consistant (homogenous) nature [40]. Nanodiscs are the 
manoeuvred or skilfully arranged forms of these reorganised HDL 
particle mimics and under optimum conditions they can assemble 
themselves into disc shaped particles of uniform size and 
configuration [41]. 
Nanodiscs in membrane protein studies 
Membrane Proteins have posed a greater challenge in different 
functional as well as biochemical studies. The major challenge lies in 
the difficulty to study membrane proteins from a mechanistic view 
point. This is because most of the chemical as well as biophysical 
methods which are relevant and appropriate to soluble enzymes 
may fail while coming in contact with the insoluble masses [42]. If 
the membrane protein is found in a solubilized condition, then it 
makes the processes like purification, assay, different biophysical 
and biochemical techniques, structural manipulations, spectro-
scopical procedures etc. simpler and also helps in sustaining the goal 
protein in a very stablecondition [43]. Over the past years, 
detergents were the main agents used in solublisation of membrane 
proteins and thus ultimately resulted in the formation of micelles 
containing detergent, membrane proteins and lipids. But the use of 
detergents has raised a major threat to the constancy of these 
membrane proteins [44]. Also the micellar stage of detergents can 
restrict the assay procedures and also exhibit unwanted optical 
properties such as in absorbance, scattering of light etc… There is 
also procedural difficulties with the usage of detergents and may 
result in denaturation as well as inactivation of the proteins 
(membrane proteins co concentrating with the target). Basically we 
can say that the traditional use of detergents in membrane protein 
studies posed some major challenges [45]. Mainly it interferes with 
the stability of the membrane protein of interest. As said above, it 
can not only interfere but also imped the different assay procedures. 
Particular phospholipids are also required to regulate the function of 
these membrane proteins. The limitations of these detergents 
resulted in the usage of liposomes for the purpose to incorporate the 
membrane proteins. But the liposomes also had their own 
limitations. The iposomes presented a large surface area, sometimes 
unstable and also hard to prepare with an exactly controlled 
stoichiometry and size. 
The limitation with liposomes paved the way for the arousal of a 
new system termed nanodiscs [46]. In this system, the target 
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membrane protein is transitorily made soluble in a detergent. The 
process is carried out in the presence of phospholipids and a helical 
protein belt, MSP which is amphipathic in nature and the belt 
surrounding the phospholipid bilayer. Then polystyrene beads 
which are hydrophobic in nature is added to the above system. This 
results in the elimination of detergents in such a way that the 
detergents get adsorbed on the surface of the biobeads. Thus the 
membrane protein is being placed in a native condition and the 
whole entity is made soluble with the help of the surrounding MSP 
belt. The major advantage of nanodisc technology is that it can be 
synthesised in different size and stoichiometry depending on the 
size of MSP belt used [47]. The nanodisc technology can also be 
made applicable to different classes of membrane Proteins. The 
major member among them is the MSP. What is being basically done 
is that monomerisation of the membrane proteins, and then we will 
conduct the solubilisation process. Finally, we will do the 
incorporation process. The protein is being incorporated into 
membrane environment [48]. By engineering different classes of 
Scaffold Proteins, different ranges of nanodiscs such as smaller, 
larger and medium sized nanodiscs can be constructed [49]. This can 
be achieved by the exact measuring of the give and take of the 
proteins and lipids within the nanodiscs, by the structural analysis of 
the consistency and uniformity of the lipoprotein complexes within 
them and also by explaining the kinetics of the lipo protein assembly 
by the use of experimental as well as theoretical procedures. The 
major as well as the most striking advantage of using nanodiscs is 
that it can be made in different size and definite stoichiometry using 
different MSP s[50]. The one dimensional view of a nanodisc has 
been shown in fig. 1 [8]. 
 
Fig. 1: One dimensional view of a nanodisc 
 
Advantages of nanodiscs over other systems 
Nanodiscs have many advantages when compared to other sysrems. 
The major ones being the provision of a native environment, 
stability, helps in the solublisation of membrane proteins etc. 
Nanodisc system provide contact to both surfaceof membrane and 
also helps in the oligomerisation of membrane proteins. The major 
advantages are as shown in table 1 [24-27
 
Table 1: Advantages of nanodiscs over other system 
Compared with liposomes, bicelles, amphipoles and other detergent micelles, nanodiscs provide a more native and genuine environment. 
Within nanodiscs, proteins present better stableness and activity. 
Helps in Solubilisation and reorientation of membrane proteins. [G-Protein coupled receptor] 
Proteins that Chromatographic techniques can be directly applied for the standard purification of membrane proteins stabilized by nanodiscs. 
Imparts water solubility to membrane proteins. 
Offers very stable environmental conditions for the membrane proteins. 
Enhances homogeneity of particles over microsomes. 
The membrane proteins remain uniformly dispersed in aqueous solutions. 
Nanodiscs can be synthesised in different size and also in different stoichiometry. It is dependent on the length of the MSP belt that is being used. 
Phospholipid bilayer provides a more native like environment for the membrane proteins. 
Proteins on the membrane surface can be better oligomerised using nanodiscs. 
Nanodiscs show better stability than the conventional methods and also over liposomes. 
Nanodiscs provide contact to both margins of the membrane. 
 
Materials required for nanodisc synthesis 
Materials required include MSPs, phospholipids and polystyrene bio 
beads [51-54].  
Membrane scaffold protein  
The membrane scaffold protein is the improved Apo A1 which is 
made using recombinant technology from human blood, is expressed 
in bacteria. Different MSP clones coding for different sized proteins 
is produced by the Sligar lab [55]. MSP is produced in a soluble form 
in Escherichia. coli and by using Ni2+
Beads must be washed with water and then using ethanol. 
Synthesis of nanodisc 
The first step involved in the synthesis of nanodisc is to collaborate 
together the MSP of appropriate class with the particular phospholipid 
or the detergent micelle. It is then followed by the elimination or 
removal of the detergent used [56]. As mentioned earlier, the size and 
stoichiometry of the nanodisc is being determined by the length of the 
scaffold protein that has been used. The MSP is actually a belt like 
structure that is wrapped around the protein. Next step is the 
determination of the phospholipid: MSP. This is a crucial step for the 
efficous assembling of nanodiscs. This has to be determined exactly for 
each new combination of MSP, the phospholipid and the protein. Then 
the protein solubilised in detergent is added to the disc mix. It has to 
be made ensured that this step is being done prior to the removal of 
the detergent. Thus the membrane protein has been merged into the 
nanodiscs. The major steps involving solublisation, detergent removal 
as well as assembling helps in the effective nanodisc synthesis and has 
been shown in fig. 2. 
Reorganisation of proteins into nanodiscsc in three different ways 
Cell free reaction system+arranged nanodiscs 
affinity chromatography; it is 




oleoyl-sn-glycero-3-phospho-L-serine are some of the most 
commonly used phospholipids in nanodisc synthesis. Generally 
zwitterionic and negatively charged lipids are mixed to enhance 
mimicking the cell membrane. Bacterial membrane lipids have also 
been used for incorporation of bacterial proteins into nanodiscs 
[30]. 
Polystyrene beads 
Detergents are not needed in this method of protein reconstitution. 
Membrane proteins can be made in cell free expression system. 
Preassembled nanodiscs are combined with the cell free reaction 
system and it ultimately results in joining or incorporation of the 
membrane protein into nano disk [57]. 
Nair et al. 




Fig. 2: Steps in nanodisc synthesis 
 
Previously solubilised membrane protein+detergent+MSP 
protein+phospholipid 
MSPs and phospholipids are added subsequently to the purified 
proteins. Nanodiscs incorporated with membrane proteins are 
formed and can be purified by chromatographic techniques. 
Detergent+MSP+protein expressed membrane 
To the protein expressed membrane, MSP s and detergents are 
added. Phospholipids, proteins etcetera in the membrane and MSP s 
align together to form the nano disc complex. This is beneficial in 
proteomic studies. Single nanodisc–protein complexes can also be 
isolated by various chromatographic techniques (affinity 
chromatography) [58, 53]. 
Nanodisc reconstitution mixtures 
Nanodisc reconstitution mixtures can be prepared by using an 
efficient way involving chloroform, lipid stocks, nitrogen steam, and 
solvent removal by vaccum dessicator, lipid drying, addition of 
sodium cholate buffer and finally vortexing and sonicating as seen in 
fig. 3[53, 22, 59-61].
 
 
Fig. 3: Preparation of nanodisc reconstitution mixtures 
 
Applications of nanodiscs 
The modern innovations in nanodiscs and cancer therapy 
The evolution of an eminent therapy for cancer has been one of the 
primarily focussed aspects not only in the medical field but also in 
terms of the society. Despite the availability of many cancer vaccines 
in the medicine field including peptide based vaccines for cancer 
therapy, their utility in humans was found to be limited only. The 
latest innovations in chemotherapy include personalised immune 
therapy which has been achieved with the aid of very specific neo 
antigens. The milestone behind this recent innovation was found to 
be due to the exome sequencing of tumour cells. The major 
limitation of this methodology was that the procedure of strongly 
activating the CD 8 alpha+responses (in the Cyto toxic T lymphocyte 
Cells) was absent. The innovatory finding signalled first of all to the 
preparation of nanodiscs which has the property of mimicking the 
HDL [62]. Then the next step was to incorporate and pair the 
antigenic peptides along with the suitable adjuvants into the 
nanodiscs. The main purpose of this step is to enhance the 
recruitment of antigen and adjuvant to the lymphoid organs. It also 
results in sustaining the antigenic concentration within the cells 
[63]. Nanodiscs can be occasioned up to 47 doubling greater rates of 
neo antigen specific Cyto toxic T lymphocyte Cells (CTL s) than 
solvable vaccines. The subsequent nanodiscs can also be constructed 
with a rate more than 31 fold frequency of the adjuvant which is the 
stronger one. This procedure has been utilised in the trials that has 
been conducted clinically. It has been found that the growth of the 
tumour cells can be potentially eliminated by efficiently utilising this 
method [64]. The method consists of vaccines involving multi 
epitopes. The link between the evolution of multi epitope vaccines 
and the inhibition of tumour growth is the generation of broad 
spectrum responses of T Lymphocyte cells. The use of nanodiscs 
resulted in the elimination of MC 38 and B16 F10 tumours. This 
innovatory process resulted due to the pairing of subsequent 
nanodiscs with anti PD1 and anti CTLA 4 therapy for cancer [65, 73-
74]. Thus these revolutionary findings that correlate nanodiscs into 
the most useful accessory for cancer therapy paved the way of the 
evolution of this upcoming system into a powerful strategy for 
cancer personalised immunotherapy. The tumour cells get mutated 
to form neoantigens. The most basic idea behind a cancer vaccine 
involving nanodisc is as follows: The nanodisc is being encumbered 
with these mutated neoantigens [66]. This neoantigen loaded 
nanodisc signal the destruction of the cancer cells. Unlike the 
traditional preventive vaccine, this new vaccine concerning nanodisc 
is a therapeutic vaccine. The principle behind this vaccine is that it 
will bout against the cancer cells in a personalised method by the 
prompting of one’s immune system [67].  
Nanodisc technology represents a revolution in the capability of our 
understanding of the functionality of membrane proteins and provide 
advanced tenacity of strategic molecular events basic to a mechanistic 
understanding of the crucial metabolic as well as signalling functions 
and further there will be implication for the upcoming of much more 
effective intervention when those basic events get disrupted during 
some particular pathological conditions [68]. 
Other applications 
Other major applications of nanodiscs include Nuclear magnetic 
Studies [69-70] surface plasma Resonance Studies [71-74], protein 
activation studies [53], binding studies of proteins etc. 
Nair et al. 




There has been constant experimenting on drug delivery studies 
ranging from nanoparticle drug delivery to microbial infectious sites 
to macromolecule studies of tissue regeneration. In the current 
scenario that finds drug targetting as one of the major challenges, 
nano drug delivery has a very important role especially in crossing 
the Blood Brain Barrier. The evolution of nanodiscs in membrane 
protein studies thus serve as a promising tool in novel drug delivery. 
The providence of a more native and genuine environment of 
nanodiscs when compared to others like liposomes, detergent 
micelles etc. once again proves the promising aspect of nanodisc. 
Nanodiscs can be synthesised in different size and also in different 
stoichiometry. It is dependent on the length of the MSP belt that is 
being used. Thus overall it can be stated as a promising novel aspect, 
in this era where a number of different tools including hydrotropes 
are under studies. 
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